AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore
National Cancer Institute at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
National Cancer Institute brings 2 presentations to AMP 2026 in Seattle. Its program covers best practice guidance for artificial intelligence and machine learning in molecular diagnostics, and an award lecture on how lymphoma diagnosis has changed over the decades. The agency funds and conducts cancer research as part of the National Institutes of Health.
| Organization | AMP 2026 Attendance |
|---|---|
National Cancer Institute Bethesda, MD | |
US federal agency funding and conducting cancer research, part of the National Institutes of Health. | Award Thu, Nov 12 8:45am–10:00am The Long and Winding Road of Lymphoma Diagnosis An award lecture on how immunological and molecular tools transformed lymphoma classification over five decades, told through case vignettes. Talk Sat, Nov 14 1:15pm–1:45pm AMP Best Practice Guidance for Artificial Intelligence (AI) and Machine Learning (ML) for Molecular Diagnostics Part 1 Working Group Best practices for validating and deploying AI models in clinical molecular workflows, and how they differ from older machine learning. |
Find decision makers at National Cancer Institute
Tell us what you sell and we’ll find the people at National Cancer Institute most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction